Lexeo Therapeutics (LXEO) Market Overview
- Current trading price: USD 3.02 per share at 10:57 AM Central Europe, Wednesday 21 Feb 2026.
- Price change: Up 4.55 % during the 24‑hour period ending at the above time.
- Share supply: 82.1 million shares outstanding.
- Market capitalization: USD 221.6 million.
- 24‑hour trading volume: Approximately USD 5.1 million.
- Monthly performance: Down 32.35 % compared with the close at the end of the previous month.
- 200‑day simple moving average: USD 5.49.
- 52‑week range: Highest price USD 10.99 (23 Dec 2025); lowest price USD 2.55 (19 Oct 2026).
Related Stock Activity (24‑Hour View)
| Symbol | Price change | Current price | Market cap | P/E ratio |
|---|---|---|---|---|
| PCYO | –1.54 % | USD 10.63 | USD 265.6 million | 18.15 |
| OACC | –0.47 % | USD 10.66 | USD 263 million | 39.09 |
| RWAY | –1.42 % | USD 6.26 | USD 265.3 million | 32.59 |
| SES | –1.96 % | USD 0.63 | USD 264.9 million | – |
| OCGN | +0.9 % | USD 0.81 | USD 264.6 million | – |
The SES (Ses Ai) stock notes a recent development: a partnership with Planet for the Pelican‑12 satellite, enhancing satellite‑to‑satellite communications through SES’s O3b mPOWER network. No additional financial data were released.
Company Profile
Lexeo Therapeutics, Inc. is a clinical‑stage gene‑therapy biotechnology firm focused on developing treatments for diseases that are currently beyond the reach of conventional drug delivery methods. The company is headquartered in New York, United States, and is listed on the Nasdaq stock exchange. Its public offering occurred on 2 November 2023. Lexeo’s operations and updates are available through its website at www.lexeotx.com .